Results

1–10 of 42 results for Uveal melanoma

Endodiode Laser With Vitrectomy-Transretinal Biopsy (EDL-VitBx) for Treatment of T1 and T2 Uveal Melanoma: Initial Results of Vision-Sparing, Definitive Local Therapy
Scott C. Oliver, MD
Annual Meeting Talks
2025
Independent Validation of a 16-Protein Test to Assess Malignant Potential of Small Uveal Melanocytic Tumors
David A Reichstein, MD
Annual Meeting Talks
2025
Detection of Germline BAP1 Mutations in Patients With Uveal Melanoma
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2025
Gene Expression Profiling Accurately Predicts Mortality for Medium and Large Uveal Melanoma: Improved Survival Outcomes for Class 1a Greater Than Class 1b Greater Than Class 2
Timothy G. Murray, MD, MBA, FASRS
Annual Meeting Talks
2025
Management of Complex Retinal Detachment in the Setting of Conservatively Treated Uveal Melanoma
Timothy G. Murray, MD, MBA, FASRS
Annual Meeting Talks
2023
Impact of Confirmatory Cytopathology on the Predictive Value of Gene Expression Profiling in Uveal Melanoma
Ivana K. Kim, MD
Annual Meeting Talks
2023
Expert Panel: Choroidal Melanoma
Basil K Williams, MD
Olufemi E Adams, M.D.
Jared T Sokol, MD, MBA
Prithvi Mruthyunjaya, MD, MHS
Annual Meeting Talks
2024
Gene Expression Profile and Local Tumor Recurrence of Irradiated Uveal Melanomas
Basil K Williams, MD
Annual Meeting Talks
2022
Prospective Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: One-Year Outcomes
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2022
Incidence of Uveal Melanoma in Kaiser Permanante Northern California
On Demand Cases, Courses, and Papers
2022